Overview

Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA-1790, Sildenafil Citrate, and Placebo

Status:
Completed

Trial end date:
2004-05-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to evaluate the hemodynamic response to a sublingual dose of glyceryl trinitrate in subjects receiving oral TA-1790, sildenafil citrate, and placebo.

Phase:

Phase 1

Details

Lead Sponsor:

VIVUS, Inc.

Treatments:

Citric Acid
Nitroglycerin
Sildenafil Citrate